Y2C

50% Upside

Long
NASDAQ:IMMU   None
0
Biotech with multiple drugs in the pipeline
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.